WGWillem Hendrik Te Gussinklo

Willem Hendrik Te Gussinklo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Willem Hendrik Te Gussinklo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Risk of sternal wound infection in bilateral skeletonized internal thoracic artery in coronary artery bypass grafting: a propensity score matching analysis

    by Willem Hendrik Te Gussinklo, Christian Burgard, Joshua Jahn, Gabriele Romano, Matthias Karck, Rawa Arif, Bashar Dib

    Background: A growing body of evidence shows that choosing an arterial graft as a second graft for coronary artery bypass grafting (CABG), has a superior patency and a survival benefit when compared to a saphenous vein graft (SVG). However, surgeons are wary to utilize the right internal mammary artery (RIMA), because of concerns of sternal wound infections (SWI). This study aims to evaluate the risk of SWI in bilateral internal mammary artery (BIMA) usage while performing skeletonized harvesting. Methods: Between January 2020 and July 2023, 1785 consecutive patients suffering from coronary artery disease (CAD) underwent a CABG operation at our hospital. Propensity score matching was performed where 259 single internal mammary artery (SIMA) patients were compared to 259 BIMA patients. We assessed sternal wound infections, and performed univariate and multivariate analysis identifying risk factors for SWI. Results: There were six (1.2%) wound infections, evenly divided between SIMA ( n = 3, 1.2%) and BIMA ( n = 3, 1.2%) groups. Multivariate testing showed female gender (OR: 3.21, 95%CI: 1.58–6.55, p = 0.001), diabetes (OR: 3.07, 95%CI: 1.42–6.61, p = 0.004, NYHA class ≥ 3 (OR: 2.38, 95%CI: 1.09–5.20, p = 0.029) and postoperative delirium (OR: 1.92, 95%CI: 1.29–2.85, p = 0.001) to be significant risk factors for SWI. BIMA grafting was not confirmed as an independent risk factor for SWI (OR: 0.66, 95%CI: 0.19–2.27, p = 0.506). Conclusion: This study shows that skeletonized BIMA grafting does not increase the risk of SWI. Female gender, diabetes, NYHA ≥ 3 and postoperative delirium did increase the risk for a sternal wound infection.

  • Open Access

    Outcomes of microaxial flow pump use in acute-on-chronic heart failure

    by W.H. Te Gussinklo, T. Azami, G. Romano, M. Eden, P. Schlegel, J. Kremer, R. Arif, M. Karck, A.L. Meyer

  • Open Access

    Are Sutureless and Rapid-Deployment Aortic Valves a Serious Alternative to TA-TAVI? A Matched-Pairs Analysis

    by Sameer Al-Maisary, Mina Farag, Willem Hendrik Te Gussinklo, Jamila Kremer, Sven T. Pleger, Florian Leuschner, Matthias Karck, Gabor Szabo, Rawa Arif

    Background: Transcatheter aortic valve implantation is a feasible alternative to conventional aortic valve replacement with expanding indication extending to low-risk patients. Sutureless and rapid-deployment aortic valves were developed to decrease procedural risks in conventional treatment. This paired-match analysis aims to compare patients undergoing surgical transcatheter aortic valve implantation to sutureless and rapid-deployment aortic valve implantation. Methods: Retrospective database analysis between 2010 and 2016 revealed 214 patients undergoing transcatheter aortic valve implantation procedures through surgical access (predominantly transapical) and 62 sutureless and rapid-deployment aortic valve procedures including 26 patients in need of concomitant coronary artery bypass surgery. After matching, 52 pairs of patients were included and analyzed. Results: In-hospital death (5.8% vs. 3.8%; p = 0.308) was comparable between transcatheter aortic valve implantation (mean age 77 ± 4.3 years) and sutureless and rapid-deployment aortic valve implantation groups (mean age 75 ± 4.0 years), including 32 females in each group. The logistic EuroSCORE was similar (19 ± 12 vs. 17 ± 10; p = 0.257). Postoperative renal failure (p = 0.087) and cerebrovascular accidents (p = 0.315) were without significant difference. The incidence of complete heart block requiring permanent pacemaker treatment was relatively low for both groups (1.9% vs. 7.7%; p = 0.169) for TAVI and sutureless and rapid-deployment valves respectively. Intraoperative use of blood transfusion was higher in the sutureless and rapid-deployment aortic valve implantation group (0.72 U vs. 1.46 U, p = 0.014). Estimated survival calculated no significant difference between both groups after 6 months (transcatheter aortic valve implantation: 74 ± 8% vs. sutureless and rapid-deployment aortic valve implantation: 92 ± 5%; log rank p = 0.097). Conclusion: Since sutureless and rapid-deployment aortic valve implantation is as safe and effective as transapical transcatheter aortic valve implantation, combining the advantage of standard diseased-valve removal with shorter procedural times, sutureless and rapid-deployment aortic valve replacement may be considered as an alternative for patients with elevated operative risk considered to be in the “gray zone” between transcatheter aortic valve implantation and conventional surgery, especially if concomitant myocardial revascularization is required.


  • Rapid exchange of an Impella 5.0. for an Impella 5.5 through the same arterial axillary access

    by Willem Te Gussinklo, Sameer Al‐Maisary